Page 4 - Charlesm Baum News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Share this article Share this article SAN DIEGO, Feb. 25, 2021 /PRNewswire/ -- Mirati Therapeutics, Inc. (NASDAQ: MRTX), a late-stage targeted oncology company, today reported financial results for the fourth quarter and full year of 2020, which reflect the company's progress across its clinical and discovery pipeline and strength as it expands its operational structure and capabilities in preparation for potential commercialization in the United States. "Our commitment to patients with cancer has enabled us to advance our two clinical programs, adagrasib and sitravatinib, as well as our pr...

Mirati Therapeutics To Present At Upcoming Healthcare Conferences 02/18/2021 | 04:16pm EDT Send by mail : Message : Required fields SAN DIEGO, Feb. 18, 2021 /PRNewswire/ -- Mirati Therapeutics, Inc. (NASDAQ: MRTX), a late-stage targeted oncology company, will participate in two upcoming healthcare conferences. Friday, February 26 th at 12:00 p.m. EST/9:00 a.m. PST at the 10 th Annual SVB Leerink Global Healthcare Conference. Dan Faga, executive vice president and chief operating officer will represent Mirati in a fireside chat at the conference. Wednesday, March 3 rd at 2:00 p.m. EST/11:00...